Listen Now

Randy Parker, Founder/CEO, Genius Rx (GeniusCo.com); the telemedicine pioneer has applied what he learned as Founder of MDLIVE to reinvent the online pharmacy to deliver greater safety, breakthrough personalized service, dramatic patient savings.

Bill Newell, CEO, Sutro Biopharma (SutroBio.com), explains how Moneyball inspired him and his team to create technology that enables them to iteratively discover and test molecules to fight cancer in a rapid cycle of weeks rather than months.

Spiro Rombotis, President/CEO, Cyclacel (Cyclacel.com). Their founding scientist Professor Sir David Lane discovered p53, a key tumor suppressor gene that malfunctions in about 2/3 of human cancers; and he oversees drug discovery and development.

Judy Guido, Guido & Associates (GuidoAssoc.com), never expected her remarkable career in business, including building companies in the GREEN industry and taking a company public on NYSE, to prepare her for stopping an axe-murderer from killing her.

James Archetto, VP, Domestic Sales, Gaumard Scientific (Gaumard.com); they design, manufacture and market simulators and cutting-edge technology for health care education for military, emergency services, major teaching hospitals, nursing schools.

Brian Culley, CEO, Lineage Cell Therapeutics (LineageCell.com); with their cell-based therapy platform, they develop and manufacture specialized, terminally-differentiated cells to replace or support human cells that are dysfunctional or absent.

Kenneth Chahine, Ph.D., J.D., CEO, Laboratory for Advanced Medicine (LAMOncoGroup.com); LAM is AI-driven and focused on commercializing early cancer detection tests from a simple blood draw. They are currently in clinical trials in the US & China.

Adam Witty, CEO, ForbesBooks, and Co-founder, BPR 360, on his partnership with former Ford CEO Alan Mullaly to bring Alan’s proprietary “Business Plan Review” or BPR to market for SMBs; Alan used BPRs to lead his amazing 2008 Ford turnaround.

Steve Adams, CEO, Tiger Neuroscience (TigerNeuro.com) talks about peak performance, this simple math equation “Performance = Skill - Interference” to explain why it’s so easy to get distracted, and how Tiger Neuro helps eliminate the interference.

Matthew Cooper, Ph.D., Founder/Chief Scientific Officer & Ayman Kabakibi, Ph.D., VP, R&D, Wugen (Wugen.com); their CAR-T platform with “off-the-shelf” fratricide-resistant CAR-T cell therapy for T-cell malignancies bridges gaps in cancer therapies.

Seth Lederman, MD, Co-Founder & CEO, Tonix Pharmaceuticals (TonixPharma.com); hear how they are using small molecules and biologics to treat psychiatric, pain and addiction conditions by improving the quality of patients’ sleep.

Raymond J. Tesi, MD, CEO & Chief Medical Officer, INmune Bio (INmuneBio.com); this clinical stage biotech company is developing new immunotherapies that reprogram the innate immune system to allow the immune system to fight cancer and Alzheimer’s.

Rob Williamson, former CEO of PharmAkea (PharmAkea.com), which was recently acquired by Galecto (Galecto.com); we talk about Rob’s amazing career journey from DJ and nightclub designer in LA to the Federal Reserve in Washington DC to healthcare.

Neil Hayward, Ph.D. is CEO of eXIthera (eXIthera.com); eXIthera is the leader in Factor XIa inhibition, the ideal target for anticoagulation. Their drug candidates are small molecules that prevent thrombosis without an increased risk in bleeding.

Gregory Verdine, Ph.D., CEO, FogPharma & LifeMine Therapeutics explains why evolution inspires so many people to go into science, and how he and his teams let evolution teach them how to discover new types of drugs. (FogPharma.com, LifeMineTX.com)

Peter Ross, CEO of Senior Helpers & Town Square. Senior Helpers is the national leader in non-medical in-home care for seniors; Town Squares are new, immersive and nostalgic enrichment centers for seniors. (SeniorHelpers.com & SHTownSquare.com)

Tim Rodell, M.D., FCCP is CEO of Aethlon Medical (AethlonMedical.com), where they have two FDA Breakthrough Designations for the same device; one Breakthrough Designation for life-threatening viral infections like Ebola and the other for oncology.

Bill Gerhart, CEO, Respivant Sciences (Respivant.com); based on promising Phase 2 results, they have initiated a Phase 2b clinical trial of RVT-1601 for patients with idiopathic pulmonary fibrosis (IPF) who suffer from a dry, persistent cough.

Ophthalmologist Dr. Ryo Kubota, CEO, Kubota Pharmaceutical Holdings (KubotaHoldings.co.jp/en/); where the mission is finding cures for blindness. A Human Research Program Investigator for NASA, he is working on a cure for blindness in astronauts.

Mike Clayman, M.D. is Co-Founder & CEO of Flexion Therapeutics (FlexionTherapeutics.com), where they are focused on advancing innovative local therapies for the treatment of patients with musculoskeletal conditions like osteoarthritis.